HI HB92 | 2016 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 22 2015 - 25% progression, died in committee
Action: 2016-01-27 - The committee(s) on HLT recommend(s) that the measure be deferred.
Pending: House Health Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Provides access for terminally ill patients to receive investigational drugs, biological products, and devices that have not received final FDA approval.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Health; Terminal Illness; Investigational Drugs, Biological Products, and Devices

Sponsors


History

DateChamberAction
2016-01-27HouseThe committee(s) on HLT recommend(s) that the measure be deferred.
2016-01-25HouseBill scheduled to be heard by HLT on Wednesday, 01-27-16 8:30AM in House conference room 329.
2015-12-17 Carried over to 2016 Regular Session.
2015-01-26HouseReferred to HLT, CPC, JUD, referral sheet 1
2015-01-22HouseIntroduced and Passed First Reading
2015-01-21HousePending introduction.

Hawaii State Sources


Bill Comments

feedback